이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

QuidelOrtho 배당금

배당금 기준 확인 0/6

QuidelOrtho 배당금을 지급한 기록이 없습니다.

주요 정보

n/a

배당 수익률

n/a

지급 비율

업계 평균 수익률	1.8%
다음 배당금 지급일	n/a
전 배당일	n/a
주당 배당금	n/a
주당 순이익	-US$26.35
3년 후 배당 수익률 예측	0%

최근 배당금 업데이트

업데이트 없음

Recent updates

QuidelOrtho: Attractive Valuation Despite Weak Performance

Apr 13

We Think QuidelOrtho (NASDAQ:QDEL) Is Taking Some Risk With Its Debt

Apr 08

QuidelOrtho Corporation's (NASDAQ:QDEL) 38% Dip In Price Shows Sentiment Is Matching Revenues

Feb 15

QuidelOrtho Corporation (NASDAQ:QDEL) Shares Could Be 38% Below Their Intrinsic Value Estimate

Mar 13

QuidelOrtho Corporation Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Feb 18

An Intrinsic Calculation For QuidelOrtho Corporation (NASDAQ:QDEL) Suggests It's 47% Undervalued

Nov 25

QuidelOrtho forecasts strong Q3 revenue above estimates, shares rise ~6% after hours

Oct 12

QuidelOrtho: Fundamentals Remain, Upbeat Financials

Sep 14

Improved Earnings Required Before QuidelOrtho Corporation (NASDAQ:QDEL) Shares Find Their Feet

Sep 03

QuidelOrtho announces $300M share repurchase authorization

Aug 17

Robust Earnings May Not Tell The Whole Story For QuidelOrtho (NASDAQ:QDEL)

Aug 13

Quidel Non-GAAP EPS of $2.34 misses by $0.51, revenue of $613.4M misses by $27.21M

Aug 04

QuidelOrtho: Continuing Its Upward Ascent

Jul 08

Calculating The Fair Value Of QuidelOrtho Corporation (NASDAQ:QDEL)

Jun 01

결제의 안정성과 성장

배당금 데이터 가져오기

안정적인 배당: 과거에 QDEL 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.

배당금 증가: QDEL 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.

시장 대비 배당 수익률

QuidelOrtho 시장 대비 배당 수익률

QDEL 배당 수익률은 시장과 어떻게 비교되나요?
세그먼트	배당 수익률
회사 (QDEL)	n/a
시장 하위 25% (US)	1.5%
시장 상위 25% (US)	4.7%
업계 평균 (Medical Equipment)	1.8%
3년 후 애널리스트 예측 (QDEL)	0%

주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 QDEL 의 배당 수익률을 평가할 수 없습니다.

고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 QDEL 의 배당 수익률을 평가할 수 없습니다.

주주에 대한 수익 배당금

수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 QDEL 의 지급 비율을 계산하기에는 데이터가 부족합니다.

주주에 대한 현금 배당금

현금 흐름 범위: QDEL 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.

QuidelOrtho 배당금

배당금 기준 확인 0/6

주요 정보

최근 배당금 업데이트

Recent updates

QuidelOrtho Corporation Suspends Earnings Guidance for the Year 2024

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

QuidelOrtho Corporation Announces CEO Changes

New major risk - Revenue and earnings growth

QuidelOrtho Corporation to Report Q1, 2024 Results on May 08, 2024

Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against QuidelOrtho Corporation and Certain Executives

QuidelOrtho: Attractive Valuation Despite Weak Performance

Labaton Keller Sucharow LLP Announces Securities Class Action Lawsuit Filed Against QuidelOrtho Corporation and Certain Executives

We Think QuidelOrtho (NASDAQ:QDEL) Is Taking Some Risk With Its Debt

Consensus EPS estimates fall by 89%

Price target decreased by 7.0% to US$56.40

QuidelOrtho Corporation Receives FDA 510(K) Clearance for its QuickVue COVID-19 Test

Consensus EPS estimates fall by 602%

QuidelOrtho Corporation Announces CEO Changes

Consensus EPS estimates have been downgraded.

QuidelOrtho Corporation's (NASDAQ:QDEL) 38% Dip In Price Shows Sentiment Is Matching Revenues

New minor risk - Share price stability

Full year 2023 earnings: EPS and revenues miss analyst expectations

QuidelOrtho Corporation Provides Earnings Guidance for the Fiscal Year 2024

President exercised options and sold US$509k worth of stock

QuidelOrtho Corporation to Report Q4, 2023 Results on Feb 13, 2024

QuidelOrtho Corporation Provides Revenue Guidance for the Year 2023

QuidelOrtho Corporation Receives 510(K) Clearance for Savanna(R) Multiplex Molecular Platform and Savanna(R) HSV 1+2/VZV PCR Assay

Price target decreased by 7.8% to US$101

QuidelOrtho Corporation Announces Board Changes

Price target decreased by 9.5% to US$110

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

QuidelOrtho Corporation Provides Earnings Guidance for the Year 2023

QuidelOrtho Corporation to Report Q3, 2023 Results on Nov 01, 2023

QuidelOrtho Corporation Receives CLIA Waiver for Sofia 2 SARS Antigen+ FIA

QuidelOrtho Corporation Announces Resignation of Christopher M. Smith from the Board, Effective August 31, 2023

Consensus EPS estimates fall by 31%

QuidelOrtho Corporation Revises Earnings Guidance for the Year 2023

New major risk - Financial position

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

QuidelOrtho Corporation to Report Q2, 2023 Results on Aug 08, 2023

Consensus EPS estimates fall by 12%, revenue upgraded

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

QuidelOrtho Corporation Revises Earnings Guidance for the Year 2023

QuidelOrtho Corporation (NASDAQ:QDEL) Shares Could Be 38% Below Their Intrinsic Value Estimate

Independent Non-Executive Chairman exercised options and sold US$538k worth of stock

QuidelOrtho Corporation Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

President exercised options and sold US$393k worth of stock

QuidelOrtho Corporation Provides Financial Guidance for the Fiscal Year 2023

President exercised options and sold US$341k worth of stock

Consensus forecasts updated

QuidelOrtho Corporation Provides Revenue Guidance for the Fourth Quarter and Full Year Ended January 1, 2023

QuidelOrtho Corporation Announces Health Canada Grants License for Quidel TriageTrue High-Sensitivity Troponin I Test to Aid in the Diagnosis of Myocardial Infarction

Investor sentiment deteriorated over the past week

QuidelOrtho Corporation Announces Executive Changes

An Intrinsic Calculation For QuidelOrtho Corporation (NASDAQ:QDEL) Suggests It's 47% Undervalued

General Counsel exercised options and sold US$173k worth of stock

High number of new directors

General Counsel exercised options and sold US$173k worth of stock

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

President & COO exercised options and sold US$16k worth of stock

Investor sentiment improved over the past week

QuidelOrtho Corporation to Report Q3, 2022 Results on Nov 02, 2022

QuidelOrtho forecasts strong Q3 revenue above estimates, shares rise ~6% after hours

Price target decreased to US$126

President & COO exercised options and sold US$14k worth of stock

QuidelOrtho: Fundamentals Remain, Upbeat Financials

Improved Earnings Required Before QuidelOrtho Corporation (NASDAQ:QDEL) Shares Find Their Feet

QuidelOrtho Corporation (NasdaqGS:QDEL) announces an Equity Buyback for $300 million worth of its shares.

QuidelOrtho announces $300M share repurchase authorization

Robust Earnings May Not Tell The Whole Story For QuidelOrtho (NASDAQ:QDEL)

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Quidel Non-GAAP EPS of $2.34 misses by $0.51, revenue of $613.4M misses by $27.21M

QuidelOrtho Corporation to Report Q2, 2022 Results on Aug 04, 2022

QuidelOrtho: Continuing Its Upward Ascent

QuidelOrtho Corporation(NasdaqGS:QDEL) dropped from Russell 2500 Growth Index

Insider exercised options and sold US$224k worth of stock

High number of new directors

Calculating The Fair Value Of QuidelOrtho Corporation (NASDAQ:QDEL)

결제의 안정성과 성장